• Xebec Adsorption (XBC) subsidiary Inmatec has received an order for 14 POC medical on-site oxygen generators for hospitals in Moldova
  • Xebec’s on-site oxygen generation products improve oxygen supply and delivery by providing an economical means for on-site production
  • On-site oxygen generation provides access to immediate, stable production at up to 60% lower cost and lower carbon emissions
  • Xebec is a global provider of clean energy solutions for renewable and low carbon gases used in energy, mobility and industrial applications
  • Xebec Adsorption (XBC) is up 1.19 per cent, trading at C$4.26 per share at 9:30 am ET

Xebec Adsorption (XBC) subsidiary Inmatec has received an order for 14 POC medical on-site oxygen generators for hospitals in Moldova.

Medical oxygen has seen surging demand as a result of the worldwide COVID-19 pandemic. Oxygen is used by patients with severe symptoms of COVID-19, in addition to patients requiring oxygen for other disease states such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and asthma.

This new demand has showcased the challenges of securing oxygen from centralized sources.

Xebec is supporting the fight against COVID-19 with its on-site oxygen generation products, which improve the supply and delivery constraints by providing an economical means for on-site production.

By adopting these products, hospitals get access to immediate, stable production at up to 60% lower cost and lower carbon emissions than traditional supply options.

“We are proud to be playing our part in fighting the novel coronavirus. Oxygen shortages continue to be rampant around the world in both developed and developing countries.

Most importantly, Inmatec enables remote hospitals to have economical access to oxygen for patients on ventilators, in operating theatres under anesthesia, and to fill cylinders. Xebec is becoming a key player in distributed gas generation with an aim to lower costs and emissions for customers,” stated Marinus van Driel, President of Xebec Europe.

In response to the pandemic, numerous governments implemented measures, adjusted regulations or made direct investments to secure adequate oxygen production. Inmatec delivered 224 oxygen generators in 2020, up from 118 in the previous year, resulting in revenue more than tripling.

Xebec expects that customers around the world will continue to recognize the benefits of on-site oxygen generation and consequently has delivered (as of March 22, 2021) 66 units in 2021 to customers around the globe and has received orders for another 67 units.

Xebec is a global provider of clean energy solutions for renewable and low carbon gases used in energy, mobility and industrial applications. The company specializes in deploying a portfolio of proprietary technologies for the distributed production of hydrogen, renewable natural gas, oxygen and nitrogen.

Xebec Adsorption (XBC) is up 1.19 per cent, trading at C$4.26 per share at 9:30 am ET.

More From The Market Online

Sintana Energy sees value after testing Mopane-1X well

Sintana Energy (TSXV:SEI) reports value-accretive testing results from the Mopane-1X well in Namibia's Orange Basin.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.
Baytex Energy - Shot from Q1 2022 drilling at the Peavine partnership in Alberta.

Baytex Energy sends a value signal to the market

Baytex Energy (TSX:BTE) piques investor interest after securing the right to buy up to 10 per cent of its public float in the U.S.